Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
KH631 / Chengdu Kanghong Pharma
NCT05672121: Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)	Recruiting	1/2	42	RoW	KH631	Chengdu Origen Biotechnology Co., Ltd.	Age-Related Macular Degeneration	12/26	12/26
NCT05657301: Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration	Recruiting	1	25	US	KH631	Chengdu Origen Biotechnology Co., Ltd.	Age-Related Macular Degeneration	09/26	09/27